Related Experiment Videos
Current issues in the treatment of hyperlipidaemias
1Department of Chemical Pathology, St Vincent's Hospital, Fitzroy, Victoria.
Australian Family Physician
|February 1, 1993
Insights
New guidelines for managing hyperlipidaemia (high cholesterol) are now available. These recommendations focus on diet and drug therapies for preventing and treating coronary heart disease.
Area of Science:
- Cardiovascular Medicine
- Public Health Policy
Background:
- A 1991 Consensus Conference reviewed evidence on lipid-lowering therapies.
- Evidence focused on primary and secondary prevention of coronary heart disease.
Purpose of the Study:
- To summarize the new Pharmaceutical Benefits Scheme (PBS) guidelines.
- Guidelines address the management of hyperlipidaemia using diet and drugs.
Main Methods:
- Review of evidence presented at the 1991 Consensus Conference on Hyperlipidaemia.
- Development of clinical guidelines for hyperlipidaemia management.
Main Results:
- Promulgation of PBS guidelines for hyperlipidaemia management.
- Guidelines integrate dietary and pharmacological interventions.
Conclusions:
- The paper provides a summary of the new PBS guidelines.
- These guidelines aim to improve the primary and secondary prevention of coronary heart disease through better hyperlipidaemia management.
Abstract:
Following the Consensus Conference on Hyperlipidaemia in Canberra in October 1991 that reviewed the evidence for lipid lowering and its effect as primary and secondary prevention of coronary heart disease PBS guidelines for the use of diet and drugs in management of hyperlipidaemia have been promulgated. The guidelines are summarised in this paper.